Incidence of Paroxysmal Atrial Fibrillation (AF) in Patients With Acute Ischemic Stroke or Transient Ischemic Attacks (TIAs) by 48 Hours Holter Monitoring

200 patients presenting with symptoms of acute ischemic stroke or transient ischemic attack were included. All patients free of AF on presentation underwent 48 hours Holter monitoring within one week.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Transient Ischemic Attack Arrhythmias, Cardiac Atrial Fibrillation Brain Diseases Brain Ischemia Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Heart Diseases Ischemic Attack, Transient Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mohamed Badr

Cairo, 11461, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient with acute ischemic stroke or TIAs (within one week of onset)

Exclusion criteria

history of persistent AF
initial ECG is AF
primary hemorrhagic stroke
acute large vessel dissection
inability or refusal of consent

Treatment and study plan

Holter ECG

Diagnostic Test

all patients will be monitored for paroxysmal Af by holder ECG

Primary outcomes

presence of paroxysmal Af

Time frame: March 2019 -November 2020

incidence of paroxysmal Af after TIA

Sponsors and collaborators

Lead sponsor

Helwan University

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2019
Study completion: 2020
First posted: Dec 22, 2020
Registry last updated: Dec 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed